Global Medical Advisory Board

Yi-Long Wu, MD (China)

Dr. Wu graduated from Sun Yat-sen University of Medical Sciences in 1982 and completed his thoracic surgery training in Germany in 1989. His main research interests include multidisciplinary synthetic therapy on lung cancer and evidence-based medicine in oncology. As vice-president of the Guangdong General Hospital & Guangdong Academy of Medical Sciences and a director of Guangdong Lung Cancer Institute, he also serves as president of the Chinese Society of Clinical Oncology(CSCO) and the president of the Chinese Thoracic Oncology Group (C-TONG).

Dr. Wu is leading the Chinese lung cancer field and has been a principle investigator or co-principle investigator in more than 90 multicenter clinical trials.A contributor to 20 books oncancer, he has also published more than 300 articles in peer-reviewed journals. He also serves on the editorial boards of Cancer Letters, Annals of Surgical Oncology, Lung Cancer Management, International Journal of Biological Marker and General Thoracic and Cardiovascular Surgery. He is editor-in-chief of Journal of Evidence-based Medicine, Journal of Thoracic Oncology (Chinese Edition) and Oncologist (Chinese Edition).

Dr. Wu also serves as president of the International Chinese Society of Thoracic Surgery (ICSTS) and is a Fellow of the American College of Surgeons.